Mounjaro gets FDA approval to lower heart attack, stroke risk in diabetes patients
The FDA approved Mounjaro to reduce the risk of heart attack, stroke and cardiovascular death in certain adults with type 2 diabetes.
The FDA approved Mounjaro to reduce the risk of heart attack, stroke and cardiovascular death in certain adults with type 2 diabetes.
What's Your Reaction?
